Novo Wins EU Recommendation for Diabetes Drug
July 25, 2014 at 07:18 AM EDT
A Novo Nordisk drug combining its long-acting insulin degludec with its type 2 diabetes treatment Victoza has been recommended for approval in Europe, in an important boost for the Danish company.
